CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Novartis AG

NVS
$284.17B
Mega Cap
NYSEPharmaceutical PreparationsPharmaceuticals🇺🇸EuropeBASEL75.9K employees

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

Website

Drugs in Pipeline

874

Phase 3 Programs

491

Upcoming Catalysts

31

Next Catalyst

Next month

Market Overview

Stock performance and key metrics

NVS News
Catalyst Timeline

33 upcoming, 3 past

No catalysts found.

33 more catalysts beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How NVS's past catalysts played out

Phase 3 readoutAug 2026+6%Phase 3 readoutFeb 2026-1%Phase 3 readoutFeb 2026+1%Phase 3 readoutJan 2026+1%PDUFA decisionOct 2019-1%PDUFA decisionMay 2019+0%
Drug Pipeline

RLX030

Phase 3

Chronic Heart Failure (CHF)

Pelacarsen

Phase 3

Hyperlipoproteinemia (a)

Secukinumab (AIN457)

Phase 3

Psoriatic Arthritis

HCQ

Phase 3

Covid-19

Ranibizumab 0.5 mg

Phase 3

Macular Edema Secondary to Branch Retinal Vein Occlusion

Tegaserod

Phase 3

Heartburn

valsartan 160 mg

Phase 3

Chronic Heart Failure

AIN457 6 mg/kg i.v.

Phase 3

Psoriatic Arthritis

Haemophilus influenzae type b (Hib) vaccine

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Phase 3

Meningococcal Meningitis

ICL670

Phase 3

Transfusional Iron Overload

amlodipine/benazepril

Phase 3

Hypertension

MenACWY-CRM + MMRV

Phase 3

Meningococcal Infections

Indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease

QIVc

Phase 3

Influenza

Lumiracoxib

Phase 3

Osteoarthritis

Gliclazide

Phase 3

Diabetes Mellitus, Type 2

Mycophenolate sodium

Phase 3

Kidney Transplantation

eH1N1_f

Phase 3

Novel 2009 Influenza H1N1

Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Valsartan/amlodipine 160/5 mg

Phase 3

Essential Hypertension

Cell culture derived seasonal trivalent influenza vaccine (cTIV)

Phase 3

Influenza

Triamcinolone acetonide 40 mg

Phase 3

Acute Gouty Arthritis Flares

[68Ga]Ga-PSMA-11

Phase 3

Prostatic Neoplasms

Ligelizumab

Phase 3

Chronic Spontaneous Urticaria

cTIV

Phase 3

Seasonal Influenza Vaccine

etanercept

Phase 3

Chronic Plaque Psoriasis

TQJ230

Phase 3

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Dexmethylphenidate HCl extended-release capsules

Phase 3

ADHD, ADD

Trivalent split influenza vaccine (TIV)

Phase 3

Influenza Disease

preservative free inactivated split influenza vaccine using the strain composition 2006/2007

Phase 3

Influenza

LCZ696

Phase 3

Heart Failure

Canakinumab (AIN457)

Phase 3

Periodic Fevers Syndrome

Verteporfin PDT

Phase 3

Pathological Myopia

Amlodipine 5 mg

Phase 3

Hypertension

Pelabresib

Phase 3

Hematologic Malignancy

QVM149 150/50/160

Phase 3

Asthma

Valsartan 0.25 mg/kg

Phase 3

Hypertension

rMenB+OMV NZ

Phase 3

Meningococcal Disease

EPO906 (Patupilone)

Phase 3

Ovarian Cancer

TIVc

Phase 3

Human Influenza

Rabies vaccines + Rabies immunoglobulins

Phase 3

Rabies Infection

Best Available Therapy (BAT)

Phase 3

Myelofibrosis

Meningococcal ACWY conjugate vaccine (MenACWY-CRM)

Phase 3

Meningococcal Disease

onasemnogene abeparvovec-xioi

Phase 3

Spinal Muscular Atrophy

No Vaccine

Phase 3

Meningococcal Disease

Ritalin LA 20 mg

Phase 3

Attention Deficit/Hyperactivity Disorder

valsartan/amlodipine

Phase 3

Hypertension

Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011

Phase 3

Seasonal Influenza

Novartis MenACWY-CRM

Phase 3

Meningococcal Disease

Rivastigmine Transdermal Patch

Phase 3

Alzheimer's Disease

BKM120

Phase 3

PI3K Pathway Activated Tumors

Ofatumumab subcutaneous injection

Phase 3

Relapsing Multiple Sclerosis

Zagreb

Phase 3

Rabies

Enteric-coated mycophenolate sodium (EC-MPS)

Phase 3

Renal Transplantation

Metformin Comparator

Phase 3

Diabetes Mellitus, Type 2

DTwP-HepB-Hib Vaccine

Phase 3

Diphtheria

Midostaurin

Phase 3

FLT3-mutated Acute Myeloid Leukemia

Haemophilus influenzae type b vaccine

Phase 3

Haemophilus Influenzae Type b

Lot A of Influenza virus vaccine

Phase 3

Influenza

Aliskiren (6.25/12.5/25 mg)

Phase 3

Hypertension

Routine Vaccines

Phase 3

Meningococcal Disease

LOU064

Phase 3

Chronic Spontaneous Urticaria

QMF149

Phase 3

Asthma

FTY 720

Phase 3

Kidney Transplantation

Tacrolimus (tacrolimus elimination)

Phase 3

Liver Transplantation

LNP023

Phase 3

IgA Nephropathy

Eltrombopag Tablets

Phase 3

Purpura, Thrombocytopenic, Idiopathic

Lamivudine

Phase 3

Hepatitis

Ali/Amlo 150/2.5 mg

Phase 3

Essential Hypertension

TIVf

Phase 3

Human Influenza

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

Phase 3

Influenza

AAA817

Phase 3

Prostate Cancer

Trivalent influenza virus vaccine (TIV)

Phase 3

Pandemic Influenza Disease

Hib-CRM197

Phase 3

Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b

Ruxolitinib

Phase 3

Primary Myelofibrosis (MF)

Investigators choice of SoC

Phase 3

Prostate Cancer

LCZ696 (sacubitril/valsartan)

Phase 3

Acute Myocardial Infarction

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease

Lapatinib

Phase 3

Neoplasms, Breast

AMG334 (70 mg) Pre-Filled Syringe (PFS)

Phase 3

Episodic Migraine

Valsartan + amlodipine 40/2.5 mg

Phase 3

Essential Hypertension

177Lu-PSMA-617

Phase 3

Prostatic Neoplasms

Fumaric acid

Phase 3

Psoriasis

AIN457 (secukinumab)

Phase 3

Psoriatic Arthritis

MenACWY-CRM

Phase 3

Meningococcal Infections

Certican®

Phase 3

Renal Interstitial Fibrosis

Inclisiran Sodium

Phase 3

ASCVD

Introduction of everolimus with reduced cyclosporine or tacrolimus dose, the earliest 1 month and the latest 6 months after liver transplantation.

Phase 3

Renal Function

diclofenac diethylamine gel 2.32%

Phase 3

Grade I/II Ankle Sprain

QAW039

Phase 3

Asthma

Methylphenidate hydrochloride

Phase 3

ADHD

Cell culture-derived influenza subunit vaccine (cTIV)

Phase 3

Influenza

Aliskiren/HCTZ

Phase 3

Hypertension

Aliskiren 150 mg tablet

Phase 3

Hypertension

Secukinumab 300 mg, s.c.

Phase 3

Giant Cell Arteritis

Entecavir

Phase 3

Hepatitis B

Inclisiran sodium 300 mg

Phase 3

Coronary Artery Disease

Certoparin

Phase 3

Persistent Nonvalvular Atrial Fibrillation

eltrombopag olamine (SB-497115-GR)

Phase 3

Purpura, Thrombocytopaenic, Idiopathic

Secukinumab 300mg

Phase 3

Palmoplantar Pustular Psoriasis

Pasireotide sub-cutaneous

Phase 3

Cushing's Disease

Salmeterol 50 μg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Imatinib mesilate

Phase 3

Refractory Desmoplastic Small Round Cell Tumors

Canakinumab 150mg in prefilled syringe

Phase 3

Acute Gouty Arthritis

Agomelatine (AGO178C)

Phase 3

Major Depressive Disorder

Olmesartan

Phase 3

Essential Hypertension

Iptacopan

Phase 3

Glomerulonephritis, IGA

Unfractionated Heparin

Phase 3

Thromboembolism

Fingolimod

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Ramipril

Phase 3

Hypertension

Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Relapsing Multiple Sclerosis

Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ

Phase 3

Essential Hypertension

Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection.

Phase 3

Ankylosing Spondylitis

Background lipid lowering therapy

Phase 3

Atherosclerotic Cardiovascular Disease

Vildagliptin 50 mg bid

Phase 3

Type 2 Diabetes Mellitus

Ceritinib

Phase 3

ALK-positive Non-small Cell Lung Cancer

QVM149

Phase 3

Asthma

Adjuvanted influenza vaccine

Phase 3

Influenza Disease

Monovalent A/H1N1 influenza vaccine

Phase 3

Pandemic Influenza

Meningococcal ACWY-CRM conjugate vaccine

Phase 3

Meningococcal Disease

BEGRIVAC

Phase 3

Seasonal Influenza

Terbinafine hydrochloride (HCl)

Phase 3

Tinea Capitis

MenACWY-CRM197 (two doses)

Phase 3

Meningococcal Meningitis

Cell culture derived influenza vaccine

Phase 3

Influenza

Iptacopan (LNP023)

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

1a - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

formoterol

Phase 3

Asthma

Influenza Virus Vaccine

Phase 3

Influenza Disease; Flu

Drug: Atrasentan

Phase 3

Berger Disease

MenACWY-CRM conjugate vaccine

Phase 3

Meningococcal Meningitis

Adjuvanted seasonal influenza vaccine

Phase 3

Influenza

Rabies

Phase 3

Rabies

Zoledronic acid 4 mg

Phase 3

Non-Small-Cell Lung Cancer

Alpelisib

Phase 3

Advanced Breast Cancer

Indacaterol 300 μg

Phase 3

Asthma

Experimental : Secukinumab low dose

Phase 3

Chronic Severe Plaque-type Psoriasis

Trivalent influenza virus vaccine (TIVf)

Phase 3

Human

RAD001

Phase 3

Metastatic Renal Cell Carcinoma

Dabrafenib

Phase 3

Melanoma

Cell culture-derived influenza vaccine

Phase 3

Influenza

AMN107

Phase 3

Gastrointestinal Stromal Tumors

Terbinafine

Phase 3

Tinea Pedis

CDZ173

Phase 3

Common Variable Immunodeficiency (CVID), APDS / PASLI

Everolimus (RAD001)

Phase 3

Tuberous Sclerosis Complex (TSC)

Licarbazepine

Phase 3

Bipolar I Disorder

Valsartan + HCTZ

Phase 3

Hypertension

Aliskiren

Phase 3

Hypertension

dovitinib

Phase 3

Hepatocellular Carcinoma

Aliskiren 150/300 mg

Phase 3

Hypertension

Bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

Pelacarsen (TQJ230)

Phase 3

Atherosclerotic Cardiovascular Disease

Meningococcal C conjugate vaccine

Phase 3

Prevention of Meningococcal Infection

Cell culture-derived trivalent subunit influenza vaccine (cTIV)

Phase 3

Influenza

Secukinumab

Phase 3

Psoriatic Arthritis

Mycophenolate sodium (enteric coated)

Phase 3

Renal Transplant

AIN457

Phase 3

Behcet Disease

Diclofenac potassium

Phase 3

Post Operative Dental Pain

valsartan+amlodipine

Phase 3

Hypertension

deferoxamine

Phase 3

Beta-Thalassemia

canakinumab (company code: ACZ885D)

Phase 3

Cryopyrin Associated Periodic Syndrome

Fingolimod 0.5 mg

Phase 3

Multiple Sclerosis

Siponimod

Phase 3

Multiple Sclerosis

AAA617

Phase 3

Oligometastatic Prostate Cancer (OMPC)

Everolimus + Cyclosporine

Phase 3

Renal Transplantation

serogroup B meningococcal vaccine

Phase 3

Meningococcal Disease

Darifenacin

Phase 3

Overactive Bladder Syndrome

Umeclidinium/vilanterol

Phase 3

Chronic Obstructive Pulmonary Disease

[18F]CTT1057

Phase 3

Prostatic Neoplasms

Salmeterol 50 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ranibizumab

Phase 3

Choroidal Neovascularization

TOBI

Phase 3

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

telbivudine or lamivudine

Phase 3

Chronic Hepatitis B

TIV1c

Phase 3

Influenza

NVA237

Phase 3

Chronic Obstructive Pulmonary Disease

rMenB+OMV NZ with routine vaccinations

Phase 3

Meningococcal Disease

Aromatase Inhibitor

Phase 3

Neoplasms, Breast

Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

Phase 3

Primary Prevention of Atherosclerotic Cardiovascular Disease

Typhoid Vi Polysaccharide Vaccine

Phase 3

Meningococcal Disease

vildagliptin + metformin

Phase 3

Diabetes Mellitus, Type 2

Relaxin

Phase 3

Heart Failure, Congestive

NVA237 50µg once daily

Phase 3

Chronic Obstructive Pulmonary Disease

Adjuvanted trivalent inactivated subunit influenza vaccine

Phase 3

Influenza, Human

Secukinumab 2 mL form

Phase 3

Psoriasis

LOU064 (blinded)

Phase 3

Chronic Spontaneous Urticaria

Osilodrostat

Phase 3

Cushing's Syndrome

Everolimus 0.25 and 0.75 mg tablets

Phase 3

Transplantation Infection

Amlodipine 10 mg

Phase 3

Hypertension

Valsartan

Phase 3

Hypertension

Secukinumab 2 mL auto-injector

Phase 3

Plaque Psoriasis

BAF312

Phase 3

Secondary Progressive Multiple Sclerosis

ABL001 40mg BID

Phase 3

Chronic Myelogenous Leukemia

cyclosporine

Phase 3

de Novo Kidney Transplant Recipients

Terbinafine hydrochloride

Phase 3

Tinea Capitis

Octreotide LAR

Phase 3

Somatostatin Receptor Positive (SSTR+)

Cyclosporine (Neoral)

Phase 3

Organ Transplantation, Renal Transplantation

Methylphenidate 20 mg long-acting capsules

Phase 3

Attention Deficit Hyperactivity Disorder

Inclisiran Sodium for injection

Phase 3

Homozygous Familial Hypercholesterolemia

paroxetine

Phase 3

Major Depressive Disorder

Zoledronic acid

Phase 3

Cancer Prostate

Ianalumab (VAY736)

Phase 3

Sjogrens Syndrome

Teriparatide

Phase 3

Osteoporosis

secukinumab 150 mg

Phase 3

Moderate to Severe Plaque-type Psoriasis

Myfortic

Phase 3

Kidney Transplantation

QVA149

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Antiepileptic drug (1 to 3 only)

Phase 3

Tuberous Sclerosis Complex-associated Refractory Seizures

Bexsero® vaccine (1 dose at study month zero)

Phase 3

Meningoccocal Disease

rMenB+OMV

Phase 3

Healthy

Vatalanib

Phase 3

Colorectal Neoplasms

Rivastigmine Patch

Phase 3

Alzheimer's Disease

Abbreviated Zagreb 2-1-1 schedule

Phase 3

Rabies

Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)

Phase 3

N. Meningitidis Carriage

QAB149

Phase 3

COPD

Valsartan 160 mg + nateglinide 60 mg

Phase 3

Diabetes Mellitus, Type 2

valsartan + simvastatin

Phase 3

HYPERTENSION

AIN457 300 mg

Phase 3

Chronic Plaque Type Psoriasis

Diclofenac sodium 1mg/g

Phase 3

Sunburn

Ranibizumab 0.3 mg - 3 times monthly, then quarterly

Phase 3

Age Related Macular Degeneration

KLU156

Phase 3

Uncomplicated Plasmodium Falciparum Malaria

thiazolidinedione (TZD)

Phase 3

Diabetes Mellitus, Type 2

NVA237 (glycopyrronium bromide)

Phase 3

Asthma

Erenumab

Phase 3

Migraine

imatinib mesylate

Phase 3

Leukemia

Diclofenac sodium

Phase 3

Acute Blunt Soft Tissue Injuries/Contusions

secukinumab 300 mg

Phase 3

Moderate to Severe Palmoplantar Psoriasis

Long-acting beta2-agonist

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

DTaP-IPV-HBV

Phase 3

Meningitis, Meningococcal

Lapatinib (GW572016) oral tablets

Phase 3

Neoplasms, Breast

QTI571

Phase 3

Severe Pulmonary Arterial Hypertension

tisagenlecleucel

Phase 3

Follicular Lymphoma

68Ga-PSMA-11

Phase 3

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

BYM338 (Bimagrumab)

Phase 3

Sporadic Inclusion Body Myositis (sIBM)

ARDT

Phase 3

Prostatic Neoplasms

oral adefovir

Phase 3

Hepatitis B, Chronic

SBR759A

Phase 3

Hyperphosphatemia

Vildagliptin 100 mg qd

Phase 3

Diabetes Mellitus, Type 2

diclofenac diethylamine, DDEA 2.32% gel

Phase 3

Osteoarthritis, Knee

Focalin XR

Phase 3

ADHD

Brolucizumab

Phase 3

Diabetic Macular Edema

Novartis Meningococcal ACWY Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Atenolol

Phase 3

Hypertension

BYM338/bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

tobramycin

Phase 3

Pseudomonas Infections

Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningitis, Meningococcal, Serogroup B

Vildagliptin

Phase 3

Diabetes Mellitus, Type 2

inactivated split influenza vaccine

Phase 3

Seasonal Influenza

Clozapine

Phase 3

Schizophrenia

indacaterol maleate

Phase 3

Asthma

Androgen Deprivation Therapy (ADT)

Phase 3

Prostate Cancer

MF59-eH1N1_f

Phase 3

Influenza

Valsartan/amlodipine 80/5 mg

Phase 3

Hypertension

LOU064 (open label)

Phase 3

Chronic Spontaneous Urticaria

Lymphodepleting chemotherapy

Phase 3

Diffuse Large B-cell Lymphoma (DLBCL)

Diclofenac Topical Sodium Gel 1%

Phase 3

Osteoarthritis

Pasireotide

Phase 3

Cushing Disease

DTaP-IPV/Hib

Phase 3

Meningococcal Disease

Dexamethasone implant and sham injections

Phase 3

Visual Impairment

ianalumab s.c. q4w

Phase 3

Lupus Nephritis

Crizanlizumab

Phase 3

Sickle Cell Disease

Best Available Therapy

Phase 3

Polycythemia Vera

Taxotere

Phase 3

Non Small Cell Lung Carcinoma

ABL001

Phase 3

Chronic Myelogenous Leukemia - Chronic Phase

Ranibizumab 0.5 mg/0.05 ml

Phase 3

Macular Edema

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)

Phase 3

Pediatric Kidney Transplantation

Ianalumab

Phase 3

Warm Autoimmune Hemolytic Anemia (wAIHA)

Valsartan and simvastatin

Phase 3

Hypertension

Pelacarsen (TQJ230) 80 mg s.c.

Phase 3

Hyperlipoproteinemia(a)

AIN457 150mg

Phase 3

Moderate to Severe Plaque-type Psoriasis

Vemurafenib

Phase 3

Melanoma

LOU064 (open-label)

Phase 3

Chronic Spontaneous Urticaria

Artemether-lumefantrine

Phase 3

Malaria

[68Ga]Ga-DOTA-TATE

Phase 3

Neuroendocrine Neoplasms

asciminib

Phase 3

Leukemia, Chronic Myelogenous

Brolucizumab 6 mg

Phase 3

Proliferative Diabetic Retinopathy

Fingolimod 1.25 mg

Phase 3

Relapsing-remitting Multiple Sclerosis

FTY720

Phase 3

Renal Transplantation

Mammalian cell based flu vaccine

Phase 3

Influenza

VAY736

Phase 3

Primary Sjogren Syndrome

Canakinumab (ACZ885)

Phase 3

Cryopyrin-Associated Periodic Syndromes

Nilotinib

Phase 3

Leukemia

secukinumab 150mg

Phase 3

Plaque-type Psoriasis

Depiquick Birch (DPG103)

Phase 3

Allergic Rhinoconjunctivitis

LCQ908

Phase 3

Non-alcoholic Fatty Liver Disease (NAFLD)

Teriflunomide capsule

Phase 3

Relapsing Multiple Scelrosis

Everolimus (Certican)

Phase 3

Heart Transplantation

Cell-Derived Trivalent Subunit Influenza Vaccine Lot 1 (cTIV)

Phase 3

Influenza

Chemotherapy

Phase 3

Acute Myeloid Leukemia (AML)

Octreotide Acetate in Microspheres

Phase 3

Diabetic Retinopathy

MenACWY CRM

Phase 3

Meningococcal Infections

standard therapy

Phase 3

Lung Transplantation

Influenza vaccine

Phase 3

Influenza

Indacaterol

Phase 3

Chronic Obstructive Pulmonary Disease

Heparin

Phase 3

Embolism

agomelatine

Phase 3

Major Depressive Disorder

Diclofenac sodium gel 1%

Phase 3

Muscle Soreness

Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1)

Phase 3

Serogroup B Meningococcal Meningitis

exemestane

Phase 3

Post Menopausal Breast Cancer

Pazopanib

Phase 3

Ovarian Cancer

Ofatumumab approved dose

Phase 3

Relapsing Multiple Sclerosis (RMS)

Indacaterol 150 μg capsules

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Combined inactivated hepatitis A & recombinant hepatitis B

Phase 3

Meningococcal Disease

rMenB + OMV NZ vaccine

Phase 3

Meningococcal Disease

[F-18]PBR06

Phase 3

Relapsing Multiple Sclerosis

Octreotide Long Acting Release

Phase 3

Chemotherapy-induced Diarrhea

Secukinumab 150 mg s.c.

Phase 3

Plaque Psoriasis

Tobramycin inhalation powder

Phase 3

Pseudomonas Aeruginosa

tamoxifen

Phase 3

Breast Cancer

LAF 237

Phase 3

Type 2 Diabetes Mellitus

Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Imatinib

Phase 3

Chronic Myeloid Leukemia

Omalizumab (Xolair)

Phase 3

Steroid and/or Prednisone Dependent Asthma

Multi-Allergen Oral Immunotherapy

Phase 3

Peanut Allergy

Bexsero®

Phase 3

Meningococcal Disease

Tobramycin solution for inhalation 300 mg

Phase 3

Cystic Fibrosis

Valsartan + Hydrochlorothiazide

Phase 3

Hypertension

Imatinib and Nilotinib

Phase 3

Leukemia, Myeloid, Chronic, BCR-ABL Positive

Aclasta

Phase 3

Prevention of BMD Loss After THR

Cyclosporin A

Phase 3

Kidney Transplantation

Novartis Investigational H5N1 vaccine

Phase 3

Influenza, Human

Tetanus toxoid vaccine

Phase 3

Relapsing Multiple Sclerosis

Goserelin

Phase 3

Advanced Metastatic Breast Cancer

Rivastigmine prevention of delirium

Phase 3

Delirium

capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)

Phase 3

Parkinson's Disease

Ritalin LA (methylphenidate hydrochloride extended release)

Phase 3

Attention Deficit/Hyperactivity Disorder

AIN457 150 mg

Phase 3

Moderate to Severe Chronic Plaque-Type Psoriasis

Novartis Seasonal Influenza Vaccine

Phase 3

Influenza, Human

Meningococcal (Groups A, C, Y and W-135) Conjugate

Phase 3

Meningitis

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

Fevipiprant 150 mg

Phase 3

Nasal Polyps

LMF237 50/250 mg

Phase 3

Diabetes Mellitus, Type 2

fluvastatin, ezetimibe

Phase 3

Dyslipidemia

Tifacogin

Phase 3

Pneumonia

Calcineurin inhibitors (CNI)

Phase 3

Liver Transplantation

Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29)

Phase 3

Influenza

indacaterol and glycopyrronium bromide (QVA149)

Phase 3

COPD

JDQ443

Phase 3

Non-Small Cell Lung Cancer

Tacrolimus (reduced tacrolimus)

Phase 3

Liver Transplant Recipient

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)

Phase 3

Influenza Virus

Indacaterol 150 μg

Phase 3

Chronic Obstructive Pulmonary Disease

Votoplam (blinded)

Phase 3

Huntington Disease

recombinant interferon alfa

Phase 3

Leukemia

Decortin

Phase 3

Uveitis, Intermediate

eltrombopag

Phase 3

Thrombocytopaenia

Zoledronic acid 5 mg solution

Phase 3

Osteoporosis

RTH258/Brolucizumab

Phase 3

Neovascular Age-Related Macular Degeneration

secukinumab low dose

Phase 3

Moderate to Severe Chronic Plaque-type Psoriasis

Cyclosporine A microemulsion

Phase 3

Chronic Plaque Psoriasis

zoledronic acid (aclasta)

Phase 3

Avascular Necrosis of Femoral Head

Tiotropium 18 μg

Phase 3

Chronic Obstructive Pulmonary Disease

TIV

Phase 3

Seasonal Influenza

TIVc_LOT A

Phase 3

Prophylaxis: Influenza

acid mycophenolic (Myfortic)

Phase 3

Nephrotic Syndrome

anthracycline ((daunorubicin or idarubicin): Induction Phase only

Phase 3

Acute Myeloid Leukemia

Fluticasone/salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

Aflibercept 2 mg

Phase 3

Neovascular Age-related Macular Degeneration

Telbivudine (LdT)

Phase 3

Chronic Hepatitis B

Lumiracoxib (drug)

Phase 3

Osteoarthritis, Hip

Diclofenac Sodium Gel

Phase 3

Osteoarthritis of the Knee

Lanzoprazole

Phase 3

Heartburn

valsartan+amlodipine combination, valsartan, amlodipine

Phase 3

Hypertension

Recombinant meningococcal B + OMV NZ

Phase 3

Meningococcal Disease

1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningococcal Disease

Aliskiren/Amlodipine 150/2.5 mg

Phase 3

Essential Hypertension

ACZ885

Phase 3

TNF-receptor Associated Periodic Syndromes (TRAPS)

androgen deprivation therapy

Phase 3

Metastatic Cancer

Capmatinib

Phase 3

Carcinoma, Non-Small-Cell Lung

Mometasone furoate/formoterol (MF/F) combination

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Zometa

Phase 3

Breast Cancer

Calcineurin inhibitors maintenance

Phase 3

Autosomal Dominant Polycystic Kidney Disease

Lansoprazole

Phase 3

Heartburn

Aliskiren 75 mg

Phase 3

Hypertension

Androgen Receptor Signalling Inhibitor (ARPI)

Phase 3

Prostate Cancer Metastatic

Meningococcal ACWY conjugate vaccine

Phase 3

Bacterial Meningitis

Abelacimab

Phase 3

Atrial Fibrillation (AF)

RTH258

Phase 3

Neovascular Age Related Macular Degeneration

Nilotinib (Tasigna ®), capsules of 150 mg

Phase 3

Chronic Myeloid Leukemia

Bosentan

Phase 3

Pulmonary Arterial Hypertension

OFC Infusion

Phase 3

Leukaemia, Lymphocytic, Chronic

rabies vaccine

Phase 3

Rabies Post-exposure Prophylaxis

Famciclovir

Phase 3

Genital Herpes

GP2017 (adalimumab biosimilar)

Phase 3

Ankylosing Spondylitis

Imatinib Mesylate (Gleevec)

Phase 3

Idiopathic Pulmonary Fibrosis

Cell derived subunit trivalent nonadjuvanted vaccine

Phase 3

Influenza

irbesartan

Phase 3

Hypertension

Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Phase 3

De Novo Renal Transplantation

Seasonal Influenza Vaccine

Phase 3

Influenza

Active Comparator

Phase 3

Alzheimer's Disease

EC-MPS

Phase 3

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Brolucizumab 6mg

Phase 3

Neovascular Age-Related Macular Degeneration

Ruxolitinib (RUX)

Phase 3

Corticosteroid Refractory Acute Graft vs Host Disease

Canakinumab 150 mg

Phase 3

Acute Gout

Labeled regime arm

Phase 3

Diabetic Macular Edema

Inclisiran

Phase 3

Familial Hypercholesterolemia - Homozygous

Crizanlizumab (SEG101)

Phase 3

Sickle Cell Disease (SCD)

VAL489

Phase 3

Pediatric Hypertension With or Without CKD

MMF

Phase 3

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Long-acting beta 2-agonist (LABA)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan + Amlodipine besilate

Phase 3

Hypertension

Mycophenolic Acid (MPA)

Phase 3

Kidney Transplantation

First line DMT

Phase 3

Multiple Sclerosis

Iptcaopan 200 mg

Phase 3

Atypical Hemolytic Uremic Syndrome

Prograf or Neoral

Phase 3

Kidney Transplantation

Pandemic influenza vaccine

Phase 3

Influenza

Meningococcal B Recombinant vaccine rMenB+OMV NZ

Phase 3

Meningococcal Disease

Secukinumab (150 mg)

Phase 3

Anklyosing Spondylitis

Everolimus and tacrolimus

Phase 3

Kidney Transplant

lisinopril

Phase 3

Hypertension

Risedronate

Phase 3

Paget's Disease of Bone

Octreotide acetate 30 mg suspension

Phase 3

Acromegaly

Pimecrolimus Cream 1%

Phase 3

Atopic Dermatitis

Daptomycin

Phase 3

Infections

Benazepril plus hydrochlorothiazide

Phase 3

Hypertension

Salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

Xylometazoline

Phase 3

Common Cold

sacubitril/valsartan

Phase 3

Heart Failure With Preserved Ejection Fraction

Octreotide

Phase 3

Thymoma

Enalapril

Phase 3

Pediatric Heart Failure

NVA237 50 µg and indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ciclosporin

Phase 3

Severe Atopic Dermatitis

rofecoxib

Phase 3

Osteoarthritis

Aliskiren 300 mg

Phase 3

Hypertension

sulfonylurea (SU)

Phase 3

Type 2 Diabetes Mellitus (T2DM)

Pimecrolimus

Phase 3

Atopic Dermatitis

Meningococcal ACWY Polysaccharide Vaccine

Phase 3

Meningococcal Meningitis

Acetaminophen 250 mg and Aspirin 250 mg

Phase 3

Acute Migraine

Mycophenolic Acid

Phase 3

Kidney Transplantation

MF59-eH1N1

Phase 3

Influenza

lapatinib ditosylate

Phase 3

Breast Cancer

MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)

Phase 3

Influenza

octreotide LAR 30mg

Phase 3

Acromegaly

INC424

Phase 3

Myelofibrosis

Ranibizumab 0.5mg

Phase 3

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

Bosutinib

Phase 3

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

basiliximab

Phase 3

Liver Transplantation

valsartan+amlodipine combination

Phase 3

Hypertension

Telbivudine

Phase 3

Hepatitis B Virus

Rivastigmine 5 cm^2

Phase 3

Alzheimer Disease

Eculizumab

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Depigoid

Phase 3

Allergic Asthma

valsartan + amlodipine

Phase 3

Hypertension

zigakibart

Phase 3

Immunoglobulin A Nephropathy (IgAN)

Rivastigmine

Phase 3

Vascular Dementia

Secukinumab (75 mg)

Phase 3

Ankylosing Spondylitis

onasemnogene abeparvovec

Phase 3

Spinal Muscular Atrophy (SMA)

FTY720 5 mg + reduced-dose Neoral (RDN) + corticosteroids

Phase 3

Kidney Transplantation

brolucuzumab 6 mg IVT

Phase 3

Age-Related Macular Degeneration

Ofatumumab

Phase 3

Relapsing Multiple Sclerosis

Deferasirox

Phase 3

Beta-thalassemia

ACZ885 150 mg (Canakinumab)

Phase 3

Systemic Juvenile Idiopathic Arthritis (SJIA)

canakinumab

Phase 3

NALP3 Mutation

IFF flavor 316 282, Paracetamol , Phenylephrine, Guaifenesin

Phase 3

Upper Respiratory Infections

Interferon beta-1a

Phase 3

Multiple Sclerosis

Candesartan+HCTZ - Phase 1

Phase 3

Hypertension

TRI476

Phase 3

Partial Onset Seizures

Ansastrozole

Phase 3

Early Breast Cancer

Aliskiren/amlodipine 300/10 mg tablet

Phase 3

Moderate to Severe Hypertension

Octreotide Acetate in Microspheres 20 mg

Phase 3

Diabetic Retinopathy

Enteric-coated Mycophenolate Sodium

Phase 3

Autoimmune Disease

Monovalent inactivated influenza vaccine

Phase 3

Pre-pandemic Influenza Vaccine

Verteporfin photodynamic therapy

Phase 3

Macular Degeneration

Glycopyrronium bromide

Phase 3

Chronic Obstructive Pulmonary Disease

Indacaterol 75 μg

Phase 3

Chronic Obstructive Pulmonary Disease

IFF flavor 316 282, Paracetamol, Pseudoephedrine

Phase 3

Upper Respiratory Infections

LOU064 25 mg (b.i.d)

Phase 3

Chronic Spontaneous Urticaria

oxcarbazepine

Phase 3

Epilepsy

Trametinib

Phase 3

Cancer

Pertuzumab

Phase 3

Advanced HER2+Breast Cancer

Fluvastatin

Phase 3

Heterozygous Familial Hypercholesterolemia

Tobramycin Solution for Inhalation

Phase 3

Cystic Fibrosis

indacaterol and glycopyrronium (QVA149)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan 160 mg capsules

Phase 3

Essential Hypertension

Certican

Phase 3

Kidney Transplantation

Zoledronic acid 5 mg iv

Phase 3

Male Osteoporosis

Artemether-lumefantrine (COA566)

Phase 3

Acute Uncomplicated Falciparum Malaria

Pasireotide LAR

Phase 3

Acromegaly

Rivastigmine capsule

Phase 3

Parkinson's Disease Dementia

Omalizumab

Phase 3

Asthma

Minimisation of TAC

Phase 3

Liver Transplant

Cyclosporine/cyclosporine microemulsion

Phase 3

Liver Transplantation

Ribociclib

Phase 3

Early Breast Cancer

Indacaterol acetate/Mometasone furoate

Phase 3

Asthma

LCZ

Phase 3

Hypertension

glycopyrronium (NVA237)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

panobinostat

Phase 3

Relapsed and Bortezomib Refractory Multiple Myeloma

CTL019

Phase 3

B-cell Acute Lymphoblastic Leukemia

Rivastigmine 5 cm^2 transdermal patch

Phase 3

Alzheimer's Disease

Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets

Phase 3

Upper Respiratory Tract Infection

Diclofenac sodium topical gel 1%

Phase 3

Ankle Sprain

interferon-alpha (INF-a)

Phase 3

Chronic Myelogenous Leukemia

QMF149 150/80 μg

Phase 3

Mild Asthma

Abatacept

Phase 3

Rheumatoid Arthritis

Eltrombopag olamine

Phase 2

Lymphoma

Conventional Therapy

Phase 2

Non-infectious Intermediate Uveitis

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Meningococcal (group B) multicomponent recombinant adsorbed vaccine.

Phase 2

Meningococcal Disease

GSK2110183 (afuresertib)

Phase 2

Cancer

Octreotide (Immediate release)

Phase 2

Peritoneal Neoplasms

TMZ

Phase 2

Medulloblastoma

QAV680

Phase 2

Seasonal Allergic Rhinitis

Midostaurin (PKC412)

Phase 2

Leukemia

VAK694; Alutard Avanz SQ

Phase 2

Seasonal Allergic Rhinitis

BION-1301 Single Dose

Phase 2

IgA Nephropathy

QAW039 capsules once daily for 28 days

Phase 2

Persistent Asthma

MenACWY-TT

Phase 2

Meningococcal Disease

RKI983A

Phase 2

Glaucoma

Treosulfane

Phase 2

Prostate Cancer

hATG

Phase 2

Aplastic Anemia

QGE031

Phase 2

Allergic Asthma

Adjuvant endocrine therapy

Phase 2

Breast Cancer

JSB462

Phase 2

Prostatic Cancer, Castration-Resistant

LTP

Phase 2

Healthy Volunteers, Pulmonary Arterial Hypertension

ITU512

Phase 2

Sickle Cell Disease

BYM338 active drug

Phase 2

Cachexia

LDK378

Phase 2

Non-Small Cell Lung Cancer

Deferasirox dispersable tablet (DT)

Phase 2

Transfusion-dependent Thalassemia

Aliskiren 3.125 mini-tablets

Phase 2

Hypertension

75 µg indacaterol maleate (LB)

Phase 2

Asthma

KAF156

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Meningococcal B vaccine

Phase 2

Meningococcal Meningitis

Influenza Vaccine, Formulation 2008-2009

Phase 2

Seasonal Influenza

rMenB

Phase 2

Meningococcal Disease

Pelacarsen (TQJ230) 80mg

Phase 2

Aortic Stenosis

MCS110

Phase 2

Pigmented Villonodular Synovitis

Omalizumab 75-375 mg

Phase 2

Chronic Urticaria

Three 1 mL doses of Rabies vaccine and two JE vaccine

Phase 2

Rabies

QAX028

Phase 2

Chronic Obstructive Pulmonary Disease

CGF166

Phase 2

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

MF59 adjuvanted H5N1 influenza vaccine

Phase 2

Influenza

EYU688

Phase 2

Dengue

DII235

Phase 2

Lipoprotein Disorder

LEZ763

Phase 2

Type II Diabetes

Indacaterol maleate 400 μg

Phase 2

Asthma

Secukinumab 10 mg/kg

Phase 2

Dry Eye

EGF816

Phase 2

Advanced Non-small Cell Lung Cancer

cyclosporine (reduced exposure) / everolimus

Phase 2

Kidney Transplantation

AEE788

Phase 2

Brain and Central Nervous System Tumors

MenACWY-CRM197

Phase 2

Meningococcal Disease

GIA632

Phase 2

Atopic Dermatitis

CPK850

Phase 2

Retinitis Pigmentosa

BAF312 solution

Phase 2

Hemorrhagic Stroke

Certoparin 3,000 IU Once Daily

Phase 2

Renal Insufficiency

QBW276

Phase 2

Pulmonary Cystic Fibrosis

short acting β2- agonist

Phase 2

COPD

valtorcitabine

Phase 2

Hepatitis B

LNA043

Phase 2

Osteoarthritis

LOU064 Arm 1

Phase 2

Chronic Spontaneous Urticaria

RAD001(everolimus)

Phase 2

Carcinoma

68Ga-FAP-2286

Phase 2

Solid Tumor

LFG316

Phase 2

Paroxysmal Nocturnal Hemoglobinuria

Sevelamer HCl

Phase 2

Chronic Kidney Disease

Seasonal Influenza Vaccine (MF59C.1)

Phase 2

Seasonal Influenza

MIJ821 Subcutaneous Injection 1 mg

Phase 2

Treatment-Resistant Depression

LFG316 Lower dose

Phase 2

Geographic Atrophy

thrombopoietin receptor agonist (TPO-RA)

Phase 2

Primary Immune Thrombocytopenia (ITP)

Dovitinib (TKI258)

Phase 2

Tumor Pathway Activations Inhibited by Dovitinib

sacubitril/valsartan (LCZ696)

Phase 2

Hypertension

NVA237 12.5 µg once daily

Phase 2

Chronic Obstructive Pulmonary Disease

Glucocorticoids

Phase 2

ANCA Associated Vasculitis (AAV)

Glycopyrronium bromide 25ug

Phase 2

Asthma

XXB750 drug

Phase 2

Resistant Hypertension

XBD173

Phase 2

Anxiety Disorders

INE963

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

CFZ533 - MMF - CS

Phase 2

Kidney Transplant Rejection

LCZ696A

Phase 2

Pharmacokinetics

alb-interferon alfa 2b

Phase 2

Chronic Hepatitis C

CFZ533

Phase 2

Lupus Nephritis

Panobinostat (LBH589)

Phase 2

Myelodysplastic Syndromes

Serelaxin

Phase 2

Labor, Induced

Rapcabtagene autoleucel

Phase 2

Idiopathic Inflammatory Myopathies

AMN107- NILOTINIB

Phase 2

Gastrointestinal Stromal Tumors (GIST)

Sumatriptan

Phase 2

Migraine

Oxybutynin

Phase 2

Healthy Volunteers

QAV680 + Cetirizine

Phase 2

Allergic Rhinitis

Influenza vaccine surface antigen adjuvanted with MF59

Phase 2

Pandemic Influenza Disease

RLX030 (serelaxin)

Phase 2

Chronic Heart Failure

Asciminib single agent

Phase 2

Chronic Myelogenous Leukemia

Pasireotide LAR and Everolimus Combination

Phase 2

Neuroendocrine Carcinoma of the Lung and Thymus

Naproxen

Phase 2

Osteoarthritis

Tropifexor (LJN452)

Phase 2

Non-alcoholic Steatohepatitis (NASH)

VHB937

Phase 2

Amyotrophic Lateral Sclerosis (ALS)

Iscalimab

Phase 2

Sjogren's Syndrome

LXE408

Phase 2

Chagas Disease

Indacaterol 27.5 mcg

Phase 2

Asthma

SPP100

Phase 2

Hypertension

PTK787

Phase 2

Wet Age-Related Macular Degeneration

Deferoxamine (DFO)

Phase 2

Sickle Cell Disease

LBH589

Phase 2

Lymphoma

ACZ885 (investigational)

Phase 2

Rheumatoid Arthritis

NVGH Vi-CRM197 12.5 mcg

Phase 2

Typhoid Fever

CFZ533 active - Cohort 1

Phase 2

Primary Sjögren's Syndrome

ARV-766 Part A&B

Phase 2

Prostate Cancer Metastatic

TNO155

Phase 2

KRAS G12C Mutant Solid Tumors

NGI226

Phase 2

Achilles Tendinopathy

AEB071

Phase 2

Uveitis

Core Study: Deferasirox

Phase 2

Transfusional Iron Overload

AQW051 2 mg (single and multiple doses)

Phase 2

Schizophrenia Disorders

AIN457A

Phase 2

Ankylosing Spondylitis

Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy

Phase 2

Attention Deficit Hyperactivity Disorder

AFQ056

Phase 2

Parkinson's Disease

Patupilone

Phase 2

Metastatic Hormone Refractory Prostate Cancer

rapcabtagene autoleucel (YTB323)

Phase 2

Progressive Multiple Sclerosis

HSC835

Phase 2

Acute Myelocytic Leukemia

PDR001

Phase 2

Melanoma

QAX576

Phase 2

Asthma

PTC518

Phase 2

Huntington Disease

Indacaterol 300μg

Phase 2

Chronic Obstructive Pulmonary Disease

LIK066

Phase 2

Elevated Body Mass Index

TKI258

Phase 2

Solid Tumors and Advanced Endometrial Cancer

QVM149 150/50/80 μg o.d.

Phase 2

Asthma

BHQ880

Phase 2

Smoldering Multiple Myeloma

DNK333

Phase 2

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Indacaterol (QAB149)

Phase 2

COPD

balicatib (AAE581)

Phase 2

Knee Osteoarthritis

Iptacopan (part 1)

Phase 2

Lupus Nephritis

MF59-eH5N1

Phase 2

Pandemic

UNR844-Cl

Phase 2

Presbyopia

Zoledronic Acid; Letrozole

Phase 2

Breast Cancer

epothilone b

Phase 2

Ovarian Neoplasms

PTK787/ZK 222584

Phase 2

Von Hippel-Lindau Disease

Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.

Phase 2

Invasive Meningococcal Disease

Fluad H5N1 Pandemic Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza Vaccine

combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine

Phase 2

Meningococcal Infections

BEZ235 (Stage 1)

Phase 2

Pancreatic Neuroendocrine Tumors (pNET)

Meningococcal Vaccine

Phase 2

Meningococcal Disease

MenABCWY+OMV

Phase 2

Meningococcal Disease

AFQ056 with L-dopa

Phase 2

Parkinson's Disease

ICL670, deferoxamine

Phase 2

Anemia, Sickle Cell

IGE025

Phase 2

Chronic Idiopathic Urticaria

DFV890

Phase 2

Coronary Heart Disease

CMK389

Phase 2

Atopic Dermatitis

Nilotinib followed by treatment-free

Phase 2

Chronic Myelogenous Leukemia

[68Ga]Ga-NeoB

Phase 2

Breast Cancer

AUY922

Phase 2

Non-small-cell Lung Cancer

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

SBR759

Phase 2

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

STI571 (Glivec®)

Phase 2

Prostatic Neoplasm

MenC-CRM LIQ

Phase 2

Meningococcal Disease

LEE011

Phase 2

Teratoma

Simulect®

Phase 2

Renal Transplantation

NVGH Vi-CRM197

Phase 2

Typhoid Fever

MenACWY-CRM conjugate vaccine, adjuvanted

Phase 2

Prevention of Meningococcal Disease

VAK694

Phase 2

Allergic Rhinitis

BFH772 1% ointment

Phase 2

Erythemato-telangiectatic Rosacea

BGT226

Phase 2

Solid Tumors

Cyclosporine A

Phase 2

Atopic Dermatitis

Dexamethasone based mouthwash

Phase 2

Advanced Breast Cancer

SMC021

Phase 2

Health Postmenopausal Women

NVA237 100 µg

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

KAE609

Phase 2

Malaria

Vi-CRM197 vaccine

Phase 2

Typhoid Fever

Infliximab

Phase 2

Crohn's Disease

SAF312A

Phase 2

Postoperative Pain

indacaterol maleate / mometasone furoate

Phase 2

Asthma

Canakinumab (investigational)

Phase 2

Rheumatoid Arthritis

mometasone furoate

Phase 2

Asthma

GSK2118436

Phase 2

Cancer

Cipargamin

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

BZF961

Phase 2

Hepatitis C

ABL001/Asciminib

Phase 2

Chronic Myeloid Leukemia (CML)

CLR325

Phase 2

Chronic Stable Heart Failure

H5N1 pandemic Influenza vaccine 3.75µg

Phase 2

Pandemic H5N1 Influenza

Evolocumab

Phase 2

Atherosclerotic Cardiovascular Disease

TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)

Phase 2

Parkinson's Disease

Rapcabtagene autoleucel single agent

Phase 2

Chronic Lymphocytic Leukemia

RFB002

Phase 2

Diabetic Macular Edema

[177Lu]Lu-DOTA-TATE

Phase 2

Extensive Stage Small Cell Lung Cancer

Indacaterol acetate

Phase 2

Asthma

MenACWY polysaccharide vaccine

Phase 2

Meningococcal Meningitis

Iloperidone crystalline formulation

Phase 2

Schizophrenia

CNP520

Phase 2

Alzheimer's Disease

Mometasone furoate/formoterol fumarate (MFF)

Phase 2

Asthma

LDE225

Phase 2

Basal Cell Carcinoma

BVS857

Phase 2

Spinal and Bulbar Muscular Atrophy

LHW090

Phase 2

Patients, Resistant Hypertension

QMF149 Twisthaler®

Phase 2

Asthma

NIC002

Phase 2

Smokers

RAD001, Letrozole 2.5mg

Phase 2

Breast Neoplasm

LCI699

Phase 2

Hypertension

IV Artesunate

Phase 2

Severe Malaria

Aliskiren/ Valsartan

Phase 2

Hypertension

MAS825

Phase 2

COVID-19 Pneumonia, Impaired Respiratory Function

QBW251

Phase 2

Pulmonary Disease, Chronic Obstructive

BYM338

Phase 2

Skeletal Muscle

DNK333 100 mg twice daily

Phase 2

Chronic Obstructive Pulmonary Disease

ECF843

Phase 2

Dry Eye

LBH589 (panobinostat)

Phase 2

Relapse/Refractory Multiple Myeloma

LFF571

Phase 2

Moderate Clostridium Difficile Infection

Pasireotide (SOM230)

Phase 2

Carcinoid Tumors

FWY003

Phase 2

Geographic Atrophy Secondary to Age-related Macular Degeneration

LLG783

Phase 2

Peripheral Artery Disease (PAD); Intermittent Claudication

KRP203 - 1.2mg

Phase 2

Subacute Cutaneous Lupus Erythematosus

Panobinostat/LBH589

Phase 2

Refractory Leukemia

Fenofibrate

Phase 2

Non Familial Chylocmicronemia Syndrome (Non-FCS)

Seasonal flu vaccine

Phase 2

Seasonal Influenza

GHZ339

Phase 2

Atopic Dermatitis

STI571 400 mg

Phase 2

Philadelphia Positive Chronic Myeloid Leukemia

AIN 457

Phase 2

Non-infectious Uveitis

CJM112

Phase 2

Hidradenitis Suppurativa (Acne Inversa)

Entacapone

Phase 2

Parkinson's Disease

STI571

Phase 2

Systemic Sclerosis, Scleroderma

Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07

Phase 2

Influenza

H5N1 Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza

VAY736 1ml PFS

Phase 2

Sjögrens Disease

DTaP-Hib-IPV

Phase 2

Meningococcal Disease

AHU377

Phase 2

Hypertension

Investigational new drug, company code: BGG492

Phase 2

Partial Onset Seizures

INC280

Phase 2

Non-small Cell Lung Cancer

Deferasirox granule formulation

Phase 2

Transfusion-dependent Anemia

Deferasirox dispersible tablet

Phase 2

Chronic Iron Overload Due to Transfusion-dependant Anemias

Daunorubicin

Phase 2

Acute Leukaemia

AMO959

Phase 2

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Group B Streptococcus Trivalent Vaccine

Phase 2

Streptococcal Infection

MenACWY-CRM Vaccine

Phase 2

Prevention of Meningococcal Disease

Influenza Trivalent Inactivated Vaccines

Phase 2

FLU

Asciminib Pediatric formulation group

Phase 2

Myeloid Leukemia, Philadelphia Positive

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine

Phase 2

Meningococcal Disease

MenABCWY

Phase 2

Meningococcal Disease

Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009

Phase 2

Influenza

BGG492

Phase 2

Photosensitive Epilepsy

Group B streptococcus vaccine

Phase 2

Streptococcal Infections

Novartis Meningococcal (MenACWY-CRM) vaccine

Phase 2

Meningococcal Disease

MenC-CRM

Phase 2

Meningococcal Meningitis

MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation)

Phase 2

Prevention of Meningococcal Disease

branaplam

Phase 2

Spinal Muscular Atrophy

SOM230 s.c.

Phase 2

Cushing's Syndrome

Panitumumab

Phase 2

Cancer

Indacaterol acetate 75 μg

Phase 2

Asthma

Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)

Phase 2

Human Influenza

Buparlisib

Phase 2

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Eplerenone

Phase 2

Essential Hypertension

Everolimus 10 mg

Phase 2

Islet Cell Carcinoma

Bridging Therapy

Phase 2

Non-Hodgkin Lymphoma

Nazartinib

Phase 2

Advanced Solid Tumors Which Are cMET-dependent

LRX712

Phase 2

Osteoarthritis (OA)

LAG525

Phase 2

Triple-negative Breast Cancer

Deferasirox DFX, DT

Phase 2

Low and Int 1-risk Myelodysplastic Syndrome

DTIC

Phase 2

Melanoma

Rabbit ATG

Phase 2

Aplastic Anemia

CSJ148

Phase 2

HCMV

SAF312

Phase 2

Postoperative Ocular Pain After PRK Surgery

Imatinib 600mg/day (Glevec is the brand name for imatinib)

Phase 2

Gastrointestinal Stromal Tumors

indacaterol maleate/mometasone furoate

Phase 2

Asthma

Votoplam

Phase 2

Huntington Disease

MEK162

Phase 2

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma

Surface antigen inactivated influenza vaccine

Phase 2

Influenza

Tulmimetostat

Phase 2

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

PTK787/ZK 222584 (vatalanib)

Phase 2

Tumors

Aliskiren 150 mg

Phase 2

Heart Failure

CAD106

Phase 2

Alzheimer Disease

LXH254

Phase 2

Melanoma

GVV858

Phase 2

Advanced HR+/HER2- Breast Cancer

AAE581

Phase 2

Osteoporosis

Trivalent subunit inactivated flu vaccine, Formulation 2010-2011

Phase 2

Seasonal Influenza

Pandemic influenza vaccine + seasonal influenza vaccine /pandemic influenza vaccine

Phase 2

Influenza

AUY922 2 mg/m2

Phase 2

Breast Cancer

aTIV

Phase 2

Human Influenza

Group B Streptococcus Trivalent Vaccine - 20/20/20 μg

Phase 2

Streptococcal Infections

LCQ908A

Phase 2

Type 2 Diabetes Mellitus

CTL019 T-cells

Phase 2

B-cell Acute Lymphoblastic Leukemia

Deferasirox (ICL670)

Phase 2

Chronic Anemia

MF59C.1-adjuvanted subunit influenza vaccine

Phase 2

Seasonal Influenza

NSAI: Letrozole or Anastrazole

Phase 2

Breast Cancer

Investigational Treatment

Phase 2

External Genital Warts

rabbit anti-thymocyte globulin (r-ATG)

Phase 2

Severe Aplastic Anemia (SAA)

Men ACWY CRM

Phase 2

Meningococcal Disease

GXV813

Phase 2

Schizophrenia

Pasireotide (SOM230), Octreotide (Sandostatin)

Phase 2

Acromegaly

DYP688

Phase 2

Metastatic Uveal Melanoma

LJN452

Phase 2

Primary Bile Acid Diarrhea

FGF401

Phase 2

Hepatocellular Carcinoma (HCC)

Asciminib add-on

Phase 2

CML

Indacaterol 150 μg via the Concept1 dry-powder inhaler

Phase 2

Asthma

Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Ranibizumab 0.3 mg

Phase 2

Diabetic Macular Edema

SOM230

Phase 2

Dumping Syndrome

HCD122

Phase 2

Non-Hodgkin's Lymphoma

Secukinmab

Phase 2

Rheumatoid Arthritis

225Ac-PSMA-R2

Phase 2

Prostate Cancer

BYM338 10 mg/kg

Phase 2

Diabetes Mellitus, Type 2

Alum

Phase 2

Alzheimer's Disease

BGJ398

Phase 2

Recurrent Glioblastoma or Other Glioma Subtypes

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Letrozole OR Anastrozole

Phase 2

Breast Cancer

EPO906 epothilone B

Phase 2

Carcinoid

KAE609 (Cipargamin)

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

RHH646

Phase 2

Osteoarthritis, Knee

high-dose imatinib

Phase 2

CML

Diclofenac diethylamine 2.32% gel

Phase 2

Ankle Sprain

indacaterol/glycopyrrolate

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

BFH772

Phase 2

Psoriasis

Part 1: LJN452

Phase 2

Primary Biliary Cholangitis

Itraconazole

Phase 2

Acute Myeloid Leukemia

ECI830

Phase 2

Advanced HR+/HER2- Breast Cancer

QCZ484

Phase 2

Hypercholesterolaemia

Atrasentan

Phase 2

IgA Nephropathy

Vi Polysaccharide (PS) vaccine

Phase 2

Typhoid Fever

Influenza Trivalent Inactivated vaccines Novartis

Phase 2

Influenza

Lapatinib/nab-Paclitaxel

Phase 2

Neoplasms, Breast

TIN816 70 mg lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

APL180

Phase 2

Coronary Heart Disease

CSJ117

Phase 2

Pulmonary Disease, Chronic Obstructive

Deferasirox and Deferoxamine

Phase 2

Cardiac Iron Overload

NIM811

Phase 2

Chronic Hepatitis C Genotype-1 Relapse

BYL719

Phase 2

Breast Cancer

Coartem

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

LKA651

Phase 2

Diabetic Macular Edema

Terlipressin acetate

Phase 2

Compensated Cirrhosis and Portal Hypertension

RAF265

Phase 2

Metastatic Melanoma

Spartalizumab

Phase 2

Carcinoma, Non-Small-Cell Lung

MIJ821

Phase 2

Depressive Disorder, Treatment-Resistant

QBX258

Phase 2

Asthma

Aggripal®

Phase 2

Human Influenza

Pimecrolimus 1% cream

Phase 2

Oral Lichen Planus

AQW051

Phase 2

Dyskinesias

BGG492A

Phase 2

Chronic Subjective Tinnitus

Tulmimetostat DL1 QD

Phase 2

Progressive Metastatic Castrate Resistant Prostate Cancer

GBS trivalent vaccine

Phase 2

GBS Disease

NZ MenB OMV vaccine (NZ98/254)

Phase 2

Meningococcal Infections

everolimus + low-dose tacrolimus

Phase 2

Highly-sensitized Kidney Transplant Recipients

Sample collection

Phase 2

Squamous Cell Anal Carcinoma

Irinotecan associated to fluorouracil and leucovorin

Phase 2

Gastric Cancer

Intravitreal ranibizumab with photodynamic therapy

Phase 2

Age Related Macular Degeneration

meningococcal B vaccine & meningococcal ACYW conjugate vaccine

Phase 2

Meningococcal Meningitis, Serogroup A

68Ga-DOTA-MGS5

Phase 2

Neuroendocrine Tumors

Oral dabrafenib and trametinib

Phase 2

Craniopharyngioma

Letrozole 2.5mg

Phase 2

Breast Cancer

Smac Mimetic LCL161

Phase 2

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Montelukast

Phase 2

Allergic Rhinitis

Alpelisib (BYL719)

Phase 2

Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)

sabatolimab

Phase 2

Myelodysplastic Syndromes

Bicalutamide

Phase 2

Triple Negative Breast Cancer

CLAG Regimen

Phase 2

Leukemia

GBS Vaccine

Phase 2

Infections, Streptococcal

Trivalent influenza vaccine (TIVc)

Phase 2

Influenza

BYL-719 (alpelisib)

Phase 2

Breast Cancer

PDR001, Imatinib

Phase 2

Gastrointestinal Stromal Tumors

Alpelisib Pill

Phase 2

Endometroid Endometrial Cancer

Octreotide Depot

Phase 2

Neuroendocrine Carcinoma

Lu-PSMA-617

Phase 2

Liver Cancer

BAT

Phase 2

Polycythemia Vera (PV)

Gleevec and Taxotere

Phase 2

Lung Cancer

Mesna

Phase 2

Leukemia

Sacubitril / Valsartan Oral Tablet [Entresto]

Phase 2

Covid19

ARPI: Abiraterone

Phase 2

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Imatinib mesylate and panitumumab

Phase 2

Colorectal Neoplasm

Zotatifin

Phase 2

Breast Cancer

Cohort 1: hATG, CsA, EPAG Day 14 to Month 6

Phase 2

Severe Aplastic Anemia

Aflunov (Single prime, single boost)

Phase 2

Influenza

Gleevec

Phase 2

Leukemia, Myeloid

Tivozanib

Phase 2

Gastrointestinal Cancer

MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO

Phase 2

Acute Myeloid Leukemia

Medroxyprogesterone Acetate

Phase 2

Advanced, Persistent, or Recurrent Endometrial Cancer

[177Lu]Lu-DOTATATE

Phase 2

Intracranial Meningioma

AAA517

Phase 2

Prostatic Neoplasm

RAD001 (Everolimus)

Phase 2

Systemic Mastocytosis

fluticasone propionate/salmeterol

Phase 2

Asthma

gemcitabine and nab paclitaxel

Phase 2

Pancreatic Cancer

LEE-011

Phase 2

Metastatic Breast Cancer

Lutetium Lu 177 Vipivotide Tetraxetan

Phase 2

Prostate Carcinoma

Canakinumab Injection

Phase 2

Myelodysplastic Syndromes

Ribociclib 400mg

Phase 2

Breast Cancer

Gleevec™

Phase 2

Lung Cancer

Sonidegib

Phase 2

Recurrent Plasma Cell Myeloma

Intravitreal injection ranibizumab

Phase 2

Type 2 Idiopathic Macular Telangiectasia

G-CSF

Phase 2

Leukemia

Imatinib Mesylate and Nilotinib

Phase 2

Graft Versus Host Disease

verteporfin

Phase 2

Macular Degeneration

3 weeks Dose Induction of Everolimus

Phase 2

Breast Cancer

Elidel

Phase 2

Seborrheic Dermatitis

Opnurasib

Phase 2

Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer

High Dose Methylprednisolone (HDMP)

Phase 2

Chronic Lymphocytic Leukemia

Visudyne

Phase 2

Age-Related Macular Degeneration

Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)

Phase 2

Hormone Receptor Positive Breast Cancer

Seasonal Allergic Rhinitis

2 drugs in this indication

IgA Nephropathy

2 drugs in this indication

Hypertension

2 drugs in this indication

Chronic Plaque Type Psoriasis

1 drug in this indication

Peritoneal Neoplasms

1 drug in this indication

Cancer

1 drug in this indication

Persistent Asthma

1 drug in this indication

PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)

1 drug in this indication

Acute Myeloid Leukemia (AML)

1 drug in this indication

Chronic Obstructive Pulmonary Disease (COPD)

1 drug in this indication

cardiovascular disease

1 drug in this indication

elevated Lp(a) and established cardiovascular disease

1 drug in this indication

atherosclerotic cardiovascular disease with elevated lipoprotein(a)

1 drug in this indication

nephrology

1 drug in this indication

primary IgAN

1 drug in this indication

immunoglobulin A nephropathy (IgAN)

1 drug in this indication

Primary IgAN (IgA Nephropathy) to slow decline of kidney function in adults at risk of disease progression

1 drug in this indication

primary immunoglobulin A nephropathy (IgAN)

1 drug in this indication

Relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) in pediatric and young adult patients

1 drug in this indication

autoimmune disease, cancer

1 drug in this indication

Hormone Receptor Positive Breast Cancer

1 drug in this indication

Pathological Myopia

1 drug in this indication

Renal Interstitial Fibrosis

1 drug in this indication

Non-infectious Intermediate Uveitis

1 drug in this indication

Meningococcal Disease

1 drug in this indication

Prostatic Neoplasms

1 drug in this indication

Medulloblastoma

1 drug in this indication

Leukemia

1 drug in this indication

Melanoma

1 drug in this indication

Influenza

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in Novartis AG's drug pipeline?→

CatalystAlert tracks 874 drug candidates in Novartis AG's (NVS) pipeline across Phase 3, Phase 2. Its lead program is RLX030 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Novartis AG's next FDA catalyst?→

Novartis AG's (NVS) next tracked catalyst is a Phase 2 expected October 1, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track NVS biotech catalysts?→

Add NVS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Novartis AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply